journal article·2022-02Open access

Together is Better: mRNA Co‐Encapsulation in Lipoplexes is Required to Obtain Ratiometric Co‐Delivery and Protein Expression on the Single Cell Level

Heyang Zhang, Jeroen Bussmann, Florian H. Huhnke, Joke Devoldere, An‐Katrien Minnaert, Wim Jiskoot, Friedhelm Serwane, Joachim Spatz, Magnus Röding, Stefaan C. De Smedt, Kevin Braeckmans, Katrien Remaut

Advanced Science· Volume 9· Issue 4

Abstract

Abstract Liposomes can efficiently deliver messenger RNA (mRNA) into cells. When mRNA cocktails encoding different proteins are needed, a considerable challenge is to efficiently deliver all mRNAs into the cytosol of each individual cell. In this work, two methods are explored to co‐deliver varying ratiometric doses of mRNA encoding red (R) or green (G) fluorescent proteins and it is found that packaging mRNAs into the same lipoplexes (mingle‐lipoplexes) is crucial to efficiently deliver multiple mRNA types into the cytosol of individual cells according to the pre‐defined ratio. A mixture of lipoplexes containing only one mRNA type (single‐lipoplexes), however, seem to follow the “first come – first serve” principle, resulting in a large variation of R/G uptake and expression levels for individual cells leading to ratiometric dosing only on the population level, but rarely on the single‐cell level. These experimental observations are quantitatively explained by a theoretical framework based on the stochasticity of mRNA uptake in cells and endosomal escape of mingle‐ and single‐lipoplexes, respectively. Furthermore, the findings are confirmed in 3D retinal organoids and zebrafish embryos, where mingle‐lipoplexes outperformed single‐lipoplexes to reliably bring both mRNA types into single cells. This benefits applications that require a strict control of protein expression in individual cells.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Virus-based gene therapy research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laboratory of General Biochemistry and Physical Pharmacy Faculty of Pharmaceutical Sciences Ghent University Ghent 9000 Belgium

Division of BioTherapeutics Leiden Academic Center for Drug Research Leiden University Leiden 2333 CC The Netherlands

Max Planck Institute for Medical Research Department of Cellular Biophysics 70569 Stuttgart Germany

Center for NanoScience Ludwig‐Maximilian‐University Munich D‐80333 Munich Germany

Faculty of Physics Ludwig‐Maximilian‐University D‐80539 Munich Germany

Munich Cluster for Systems Neurology (SyNergy) D‐81377 Munich Germany

Department of Biophysical Chemistry University of Heidelberg 69120 Heidelberg Germany

RISE Research Institutes of Sweden Bioeconomy and Health, Agriculture and Food Göteborg 41276 Sweden

Department of Mathematical Sciences Chalmers University of Technology and University of Gothenburg Göteborg 41296 Sweden

Cancer Research Institute Ghent (CRIG) Ghent University Ghent 9000 Belgium

Center for Advanced Light Microscopy Ghent University Ghent 9000 Belgium

Funding

China Scholarship Council · European Research Council · Deutsche Forschungsgemeinschaft · Chinese Government Scholarship

References (46)

Show source-provided references
1. 10.1038/nrd427810.1038/nrd4278 ↗
2. 10.1016/j.nantod.2018.10.00510.1016/j.nantod.2018.10.005 ↗
3. 10.1021/acs.molpharmaceut.0c0061810.1021/acs.molpharmaceut.0c00618 ↗
4. 10.1056/NEJMoa203457710.1056/NEJMoa2034577 ↗
5. 10.1056/NEJMoa203538910.1056/NEJMoa2035389 ↗
6. 10.3390/vaccines902008110.3390/vaccines9020081 ↗
7. 10.3390/pharmaceutics1202010210.3390/pharmaceutics12020102 ↗
8. 10.1002/adbi.20200005710.1002/adbi.202000057 ↗
9. 10.1038/natrevmats.2017.5610.1038/natrevmats.2017.56 ↗
10. 10.1016/j.jconrel.2021.02.02610.1016/j.jconrel.2021.02.026 ↗
11. 10.1016/j.bbrc.2010.02.15010.1016/j.bbrc.2010.02.150 ↗
12. 10.1038/s41467-018-03190-310.1038/s41467-018-03190-3 ↗
13. 10.1038/s41586-020-2537-910.1038/s41586-020-2537-9 ↗
14. 10.1016/j.vaccine.2018.01.02910.1016/j.vaccine.2018.01.029 ↗
15. 10.1038/s41422-020-00392-710.1038/s41422-020-00392-7 ↗
16. 10.1056/NEJMcibr200973710.1056/NEJMcibr2009737 ↗
17. 10.1016/j.actbio.2018.05.01610.1016/j.actbio.2018.05.016 ↗
18. 10.1016/j.jconrel.2004.11.01910.1016/j.jconrel.2004.11.019 ↗
19. 10.1021/bi060351b10.1021/bi060351b ↗
20. 10.1007/s40820-020-00523-010.1007/s40820-020-00523-0 ↗
21. 10.1016/j.jconrel.2007.10.02410.1016/j.jconrel.2007.10.024 ↗
22. 10.1038/nnano.2010.27710.1038/nnano.2010.277 ↗
23. Patton C. · Nature · 2018 · 15 · 217
24. 10.1016/j.ymthe.2018.03.01010.1016/j.ymthe.2018.03.010 ↗
25. 10.1038/s42003-021-02441-210.1038/s42003-021-02441-2 ↗
26. 10.1073/pnas.172054211510.1073/pnas.1720542115 ↗
27. 10.1016/j.nano.2013.11.00810.1016/j.nano.2013.11.008 ↗
28. 10.1002/jbio.20200020010.1002/jbio.202000200 ↗
29. 10.1016/j.nantod.2014.04.01110.1016/j.nantod.2014.04.011 ↗
30. 10.1038/s41467-020-14527-210.1038/s41467-020-14527-2 ↗
31. 10.1016/j.nantod.2018.06.00710.1016/j.nantod.2018.06.007 ↗
32. 10.1039/D0NA00454E10.1039/D0NA00454E ↗
33. 10.1016/j.drudis.2015.07.00910.1016/j.drudis.2015.07.009 ↗
34. 10.1007/s00109-020-01956-110.1007/s00109-020-01956-1 ↗
35. 10.1002/bit.2260410.1002/bit.22604 ↗
36. 10.1016/j.celrep.2018.02.01410.1016/j.celrep.2018.02.014 ↗
37. 10.1126/sciadv.abc945010.1126/sciadv.abc9450 ↗
38. 10.1021/acs.nanolett.8b0110110.1021/acs.nanolett.8b01101 ↗
39. 10.1016/j.jconrel.2010.12.01110.1016/j.jconrel.2010.12.011 ↗
40. 10.1016/j.jconrel.2014.09.00110.1016/j.jconrel.2014.09.001 ↗
41. 10.1016/j.virol.2004.07.03310.1016/j.virol.2004.07.033 ↗
42. 10.1021/nn304949410.1021/nn3049494 ↗
43. 10.1021/acsnano.7b0758310.1021/acsnano.7b07583 ↗
44. 10.1016/j.stemcr.2016.03.00110.1016/j.stemcr.2016.03.001 ↗
45. 10.1038/nature0994110.1038/nature09941 ↗
46. 10.1073/pnas.080307810510.1073/pnas.0803078105 ↗